Dr. Lisa Mathews interviews Dr. Min Dong and Dr. Meenakshi Rao of the Boston Children’s Hospital regarding new research published in Nature that shows two FDA-approved drugs can alter our body’s own immune response to treat Clostridioides difficile (C. diff) more effectively.Continue reading “Episode #49: Treating C. diff by Reducing the Associated Inflammation (research shows that it works in mice)”
This summer, four new biosimilar drugs became available to U.S. patients and several more are expected to hit the market soon.
Dr. Michael Weinstein interviews Laura D. Wingate, executive vice president, education, support, & advocacy for the Crohn’s & Colitis Foundation about the positive and negative implications of this development for patients.Continue reading “Episode #48: New Biosimilars Available to Treat IBD (what it means for your patients)”
Dr. Lisa Mathew interviews Dr. Veena Shankaran, co-director of Hutchinson Institute for Cancer Outcomes Research, about a new study that found most patients with metastatic colorectal cancer face financial hardship after diagnosis.Continue reading “Episode #47: Let’s Talk About the Financial Burden of a Colorectal Cancer Diagnosis (and how it affects outcomes for patients)”
Dr. Fred Rosenberg interviews Harold Miller, president and CEO of the Center for Healthcare Quality and Payment Reform, national policy center that works to improve healthcare payment and delivery systems.Continue reading “Episode #46: Developing Better Healthcare Payment Models (that don’t reward consolidation at the expense of private practice)”